Therapeutic Goods (Listed Medicines—Compliance Reviews) Specification 2019 (Cth)

Therapeutic Goods (Listed Medicines Compliance Reviews) Specification 2019

I, John Skerritt, as delegate of the Minister for Health, make the following specification.

Dated 22 November 2019

Adjunct Professor John Skerritt Deputy Secretary Health Products Regulation Group Department of Health

Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Therapeutic goods information 6 Repeals Schedule 1—Specified kinds of therapeutic goods information Schedule 2Repeals Therapeutic Goods Information (Outcomes of Compliance Reviews of Listed Complementary Medicines) Specification 2012

1 Name This instrument is the Therapeutic Goods (Listed MedicinesCompliance Reviews) Specification 2019.

2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument The day after this instrument is registered.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority This instrument is made under subsection 61(5D) of the Therapeutic Goods Act 1989.

4 Definitions

Note: A number of expressions used in this instrument are defined in section 3 of the Act, including the following: (a) label; (b) listing number; (c) manufacture; (d) medicine; (e) Register; and (f) Secretary.